|
Market Closed -
Nasdaq
20:00:00 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 22.50 USD | -18.30% |
|
-10.22% | -25.84% |
| 10-28 | Rapport Therapeutics Prices Stock, Convertible Notes Offerings; Private Placement; Shares Fall | MT |
| 10-28 | Top Premarket Decliners | MT |
| Market Cap | 1.08B 969M 895M 811M 1.52B 103B 1.53B 10.71B 4.26B 53.8B 4.05B 3.97B 171B | P/E 2026 * |
-5.61x | P/E 2027 * | -4.59x |
|---|---|---|---|---|---|
| Enterprise Value | 749M 672M 621M 563M 1.05B 71.33B 1.06B 7.43B 2.96B 37.33B 2.81B 2.75B 119B | EV / Sales 2026 * |
37.3x | EV / Sales 2027 * | - |
| Free-Float |
96.09% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RAPP | Delayed | |
CBOE
| RAPP | Real-time |
Last Transcript: Rapport Therapeutics, Inc.
| 1 day | -18.30% | ||
| 1 week | -10.22% | ||
| Current month | -33.04% | ||
| 1 month | -32.72% | ||
| 3 months | -46.38% | ||
| 6 months | -33.31% | ||
| Current year | -25.84% |
| 1 week | 22.06 |  | 28.31 |
| 1 month | 22.06 | | 34.48 |
| Current year | 22.06 | | 52.93 |
| 1 year | 22.06 | | 52.93 |
| 3 years | 6.43 | | 52.93 |
| 5 years | 6.43 | | 52.93 |
| 10 years | 6.43 | | 52.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Abraham Ceesay
CEO | Chief Executive Officer | 48 | 31/01/2023 |
David Bredt
CTO | Chief Tech/Sci/R&D Officer | 61 | 31/12/2022 |
Troy Ignelzi
DFI | Director of Finance/CFO | 58 | 31/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
James Healy
BRD | Director/Board Member | 61 | 22/08/2023 |
Abraham Ceesay
BRD | Director/Board Member | 48 | 28/02/2023 |
Reid Huber
BRD | Director/Board Member | 54 | 31/01/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/10/26 | Sell | Chief Executive Officer | -1,147 | 0.0024% | ||
| 30/09/26 | Sell | Chief Operating Officer | -10,000 | 0.0208% | ||
| 23/09/26 | Sell | Chief Executive Officer | -2,210 | 0.0046% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -18.30% | -10.22% | -22.31% | - | 1.08B | |
| +0.65% | -3.36% | +36.98% | +60.50% | 64.14B | |
| +1.28% | +3.01% | +12.62% | +84.50% | 55.53B | |
| +1.48% | +1.50% | +12.73% | +104.69% | 53.03B | |
| +2.76% | +0.87% | +27.92% | +55.07% | 45.99B | |
| +2.00% | -3.39% | +17.83% | +119.04% | 42.45B | |
| +1.34% | -2.86% | +224.43% | +914.08% | 40.45B | |
| +0.64% | -3.95% | +11.15% | +45.57% | 32.25B | |
| -2.35% | +42.43% | +103.34% | +89.85% | 34.47B | |
| -2.72% | -0.44% | +23.18% | -10.77% | 24.23B | |
| Average | -1.32% | +2.65% | +44.79% | +162.50% | 39.36B | |
| Weighted average by Cap. | +0.80% | +3.45% | +49.10% | +160.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 20.06M 18M 16.64M 15.07M 28.16M 1.91B 28.5M 199M 79.25M 1B 75.29M 73.7M 3.17B | - |
| Net income | -193M -173M -160M -145M -271M -18.37B -274M -1.91B -762M -9.61B -724M -709M -30.52B | -254M -228M -210M -191M -356M -24.16B -360M -2.52B -1B -12.64B -952M -932M -40.14B |
| Net Debt | -331M -297M -274M -248M -464M -31.48B -470M -3.28B -1.31B -16.47B -1.24B -1.21B -52.29B | -309M -278M -257M -232M -434M -29.46B -439M -3.07B -1.22B -15.42B -1.16B -1.14B -48.94B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | US$22.50 | -18.30% | 5,960,886 |
| 27/10/26 | US$27.54 | +8.72% | 703,926 |
| 26/10/26 | US$25.33 | -2.31% | 1,041,210 |
| 23/10/26 | US$25.93 | -2.26% | 1,185,460 |
| 22/10/26 | US$26.53 | +5.87% | 1,459,476 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RAPP Stock
Select your edition
All financial news and data tailored to specific country editions
